Specificity: CCKBR Antibody detects endogenous levels of total CCKBR.
Host: Rabbit
Application: WB, IHC, IF/ICC
Species Reactivity: Human; Predicted: Pig, Bovine, Horse, Sheep, Rabbit, Dog
Summary
Specifications
Antibody Isotype
IgG
Species Reactivity
Human
Immunogen
A synthesized peptide derived from human CCKBR, corresponding to a region within N-terminal amino acids.
Conjugate
Unconjugated
Applications
Application Notes
WB 1:500-1:2000 IHC 1:50-1:200 IF/ICC 1:100-1:500
General Notes
This product (Catalog No. DPABH-02438) is a rabbit-derived polyclonal antibody raised against human CCKBR. It has been affinity purified by Protein A. This gene encodes a G-protein coupled receptor for gastrin and cholecystokinin (CCK), regulatory peptides of the brain and gastrointestinal tract. This protein is a type B gastrin receptor, which has a high affinity for both sulfated and nonsulfated CCK analogs and is found principally in the central nervous system and the gastrointestinal tract. Alternative splicing results in multiple transcript variants. A misspliced transcript variant including an intron has been observed in cells from colorectal and pancreatic tumors. DPABH-02438 is suitable for use in WB 1 (500-1:2000), IHC 1 (50-1:200), IF/ICC 1 (100-1:500) applications. DPABH-02438 is supplied as a liquid formulation in Phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. For long-term storage, keep at −20 °C. For short-term use, store at 2–8 °C. Avoid repeated freeze–thaw cycles to maintain antibody integrity and performance.
My Review for Rabbit Anti-Human CCKBR (N-terminal) Polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.